Labcorp Holdings Inc (BSP:L1CA34)
R$ 309.8 0 (0%) Market Cap: 103.65 Bil Enterprise Value: 139.66 Bil PE Ratio: 44.11 PB Ratio: 2.33 GF Score: 78/100

Q2 2019 Laboratory Corporation of America Holdings Earnings Call Transcript

Jul 25, 2019 / 01:00PM GMT
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Q2 2019 LabCorp Earnings Conference Call. (Operator Instructions). As a reminder, this conference call is being recorded for replay purposes. It is now my pleasure to hand the conference over to, Ms. Clarissa Willett, VP of Investor Relations. Ma'am, you may begin.

Clarissa Willett
Laboratory Corporation of America Holdings - VP of IR

Good morning and welcome to LabCorp's Second Quarter 2019 Conference Call. As detailed in today's press release, there will be a replay of this conference call available via telephone and Internet.

With me today are Dave King, Chairman and Chief Executive Officer; Glenn Eisenberg, Executive Vice President and Chief Financial Officer; and John Ratliff, CEO of Covance Drug Development.

This morning, in the Investor Relations section of our website at www.labcorp.com, we posted both our press release and Investor Relations presentation with additional information on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot